2026 News Archive

210 articles

July 2026

June 2026

May 2026

April 2026

legal

Asbestos Trust Funds for Georgia Workers

How Georgia shipyard workers, paper mill employees, and construction tradespeople can file asbestos trust fund claims. Key trusts and filing process.

legal

Asbestos Trust Funds for Iowa Workers

How Iowa manufacturing, meatpacking, and agricultural equipment workers can file asbestos trust fund claims. Key trusts and filing process.

legal

Asbestos Trust Funds for Ohio Workers

How Ohio steelworkers, auto workers, and pipefitters can file asbestos trust fund claims. Key trusts, eligibility, and filing process.

legal

Iowa Mesothelioma Verdicts and Settlements

Iowa mesothelioma litigation, including the Kinseth v. Weil-McLain $6.5M verdict reversed on appeal and the 2022 Beverage v. Alcoa ruling on Chapter 686B scope.

legal

Asbestos Trust Funds for Maryland Workers

How Maryland shipyard, steel, and insulation workers file claims against the Porter Hayden, Wallace & Gale, and other asbestos trusts tied to the state.

legal

Asbestos Trust Funds for Oregon Workers

How Oregon shipyard, mill, and construction workers can file asbestos trust fund claims. Key trusts, eligibility, and the filing process explained.

March 2026

February 2026

treatment

DREAM3R: Durvalumab Plus Chemo Falls Short

DREAM3R Phase 3 trial of durvalumab plus chemotherapy for pleural mesothelioma stopped early due to enrollment challenges. A 58% response rate, but no proof.

January 2026

clinical-trials

UTC CAR-T Phase 1 Trial (NCT06256055)

UTC Therapeutics Phase 1 trial of UCMYM802, a circular-mRNA anti-mesothelin CAR-T for mesothelin-positive solid tumors including mesothelioma.

clinical-trials

NCI HIPEC Phase 1 Trial (NCT04847063)

PHASE1 clinical trial testing HIPEC (heated intraperitoneal chemotherapy) for mesothelioma. Trial NCT04847063 is recruiting.

clinical-trials

NCI HIPEC Phase 2 Trial (NCT05001880)

PHASE2 clinical trial testing HIPEC (heated intraperitoneal chemotherapy) for mesothelioma. Trial NCT05001880 is recruiting.

clinical-trials

MSK HIPEC Phase 2 Trial (NCT06057935)

Phase 2 trial (NCT06057935) for peritoneal mesothelioma: cytoreductive surgery plus HIPEC, then intraperitoneal or IV chemotherapy. Enrolling at MSK New York.

exposure

Advocates Sue for East Wing Asbestos Records

ADAO sues for asbestos records from Trump's White House East Wing demolition. No abatement paperwork filed with D.C. regulators despite rapid 3-day teardown.

research

New Review Maps BAP1 Loss in Mesothelioma

New Oncogene review maps BAP1 loss mechanisms in mesothelioma. 65% of cases involve BAP1 inactivation; EZH2 inhibitors emerge as potential targeted therapy.

legal

$42.6M J&J Talc Verdict in Massachusetts

Massachusetts jury awards $42.6 million to Paul Lovell's family in mesothelioma verdict against Johnson & Johnson over talc powder contamination.

exposure

Montana Windstorm Scatters School Asbestos

A December windstorm ripped the roof off a Park City, Montana school gym, spreading asbestos insulation into 15 homes. EPA is conducting free cleanup.

research

Cell Therapy Shrinks Tumors in 63%

A new cell therapy achieved tumor shrinkage in 63% of advanced mesothelioma patients. More than double typical response rates.

exposure

Cassiar: The Town That Asbestos Built

For 40 years, Cassiar, BC mined chrysotile asbestos while 50,000 residents came and went. Now, former residents say they were never warned.